Depreciation of ORACLE CORP from 31 May 2010 to 31 Aug 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ORACLE CORP quarterly and annual Depreciation in USD history and change rate from 31 May 2010 to 31 Aug 2025.
  • ORACLE CORP Depreciation for the quarter ending 31 Aug 2025 was $1,351,000,000, a 68% increase year-over-year.
  • ORACLE CORP annual Depreciation for 2024 was $3,867,000,000, a 24% increase from 2023.
  • ORACLE CORP annual Depreciation for 2023 was $3,129,000,000, a 24% increase from 2022.
  • ORACLE CORP annual Depreciation for 2022 was $2,526,000,000, a 28% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ORACLE CORP Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,351,000,000 +$547,000,000 +68% 01 Jun 2025 31 Aug 2025 10-Q 10 Sep 2025 2026 Q1
Q3 2024 $804,000,000 +$92,000,000 +13% 01 Jun 2024 31 Aug 2024 10-Q 10 Sep 2025 2026 Q1
Q3 2023 $712,000,000 +$165,000,000 +30% 01 Jun 2023 31 Aug 2023 10-Q 10 Sep 2024 2025 Q1
Q3 2022 $547,000,000 +$93,000,000 +20% 01 Jun 2022 31 Aug 2022 10-Q 12 Sep 2023 2024 Q1
Q3 2021 $454,000,000 +$98,000,000 +28% 01 Jun 2021 31 Aug 2021 10-Q 13 Sep 2022 2023 Q1
Q3 2020 $356,000,000 +$20,000,000 +6% 01 Jun 2020 31 Aug 2020 10-Q 13 Sep 2021 2022 Q1
Q3 2019 $336,000,000 +$50,000,000 +17% 01 Jun 2019 31 Aug 2019 10-Q 15 Sep 2020 2021 Q1
Q3 2018 $286,000,000 +$1,000,000 +0.35% 01 Jun 2018 31 Aug 2018 10-Q 13 Sep 2019 2020 Q1
Q3 2017 $285,000,000 +$63,000,000 +28% 01 Jun 2017 31 Aug 2017 10-Q 19 Sep 2018 2019 Q1
Q3 2016 $222,000,000 +$3,000,000 +1.4% 01 Jun 2016 31 Aug 2016 10-Q 18 Sep 2017 2018 Q1
Q3 2015 $219,000,000 +$59,000,000 +37% 01 Jun 2015 31 Aug 2015 10-Q 19 Sep 2016 2017 Q1
Q3 2014 $160,000,000 +$10,000,000 +6.7% 01 Jun 2014 31 Aug 2014 10-Q 18 Sep 2015 2016 Q1
Q3 2013 $150,000,000 +$23,000,000 +18% 01 Jun 2013 31 Aug 2013 10-Q 23 Sep 2014 2015 Q1
Q3 2012 $127,000,000 +$10,000,000 +8.5% 01 Jun 2012 31 Aug 2012 10-Q 20 Sep 2013 2014 Q1
Q3 2011 $117,000,000 +$18,000,000 +18% 01 Jun 2011 31 Aug 2011 10-Q 24 Sep 2012 2013 Q1
Q3 2010 $99,000,000 01 Jun 2010 31 Aug 2010 10-Q 23 Sep 2011 2012 Q1

ORACLE CORP Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,867,000,000 +$738,000,000 +24% 01 Jun 2024 31 May 2025 10-K 18 Jun 2025 2025 FY
2023 $3,129,000,000 +$603,000,000 +24% 01 Jun 2023 31 May 2024 10-K 18 Jun 2025 2025 FY
2022 $2,526,000,000 +$554,000,000 +28% 01 Jun 2022 31 May 2023 10-K 18 Jun 2025 2025 FY
2021 $1,972,000,000 +$435,000,000 +28% 01 Jun 2021 31 May 2022 10-K 20 Jun 2024 2024 FY
2020 $1,537,000,000 +$155,000,000 +11% 01 Jun 2020 31 May 2021 10-K 20 Jun 2023 2023 FY
2019 $1,382,000,000 +$152,000,000 +12% 01 Jun 2019 31 May 2020 10-K 21 Jun 2022 2022 FY
2018 $1,230,000,000 +$65,000,000 +5.6% 01 Jun 2018 31 May 2019 10-K 21 Jun 2021 2021 FY
2017 $1,165,000,000 +$165,000,000 +16% 01 Jun 2017 31 May 2018 10-K 22 Jun 2020 2020 FY
2016 $1,000,000,000 +$129,000,000 +15% 01 Jun 2016 31 May 2017 10-K 21 Jun 2019 2019 FY
2015 $871,000,000 +$159,000,000 +22% 01 Jun 2015 31 May 2016 10-K 22 Jun 2018 2018 FY
2014 $712,000,000 +$104,000,000 +17% 01 Jun 2014 31 May 2015 10-K 27 Jun 2017 2017 FY
2013 $608,000,000 +$62,000,000 +11% 01 Jun 2013 31 May 2014 10-K 22 Jun 2016 2016 FY
2012 $546,000,000 +$60,000,000 +12% 01 Jun 2012 31 May 2013 10-K 25 Jun 2015 2015 FY
2011 $486,000,000 +$118,000,000 +32% 01 Jun 2011 31 May 2012 10-K 26 Jun 2014 2014 FY
2010 $368,000,000 +$70,000,000 +23% 01 Jun 2010 31 May 2011 10-K 26 Jun 2013 2013 FY
2009 $298,000,000 01 Jun 2009 31 May 2010 10-K 26 Jun 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.